- Home
- THFF vs ARCT Comparison
THFF vs ARCT Comparison
Compare THFF & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THFF
- ARCT
- Stock Information
- Founded
- THFF 1984
- ARCT 2013
- Country
- THFF United States
- ARCT United States
- Employees
- THFF N/A
- ARCT N/A
- Industry
- THFF Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- THFF Finance
- ARCT Health Care
- Exchange
- THFF Nasdaq
- ARCT Nasdaq
- Market Cap
- THFF 625.8M
- ARCT 298.3M
- IPO Year
- THFF N/A
- ARCT N/A
- Fundamental
- Price
- THFF $55.88
- ARCT $13.78
- Analyst Decision
- THFF Buy
- ARCT Strong Buy
- Analyst Count
- THFF 3
- ARCT 8
- Target Price
- THFF $56.50
- ARCT $52.83
- AVG Volume (30 Days)
- THFF 60.3K
- ARCT 474.9K
- Earning Date
- THFF 07-22-2025
- ARCT 08-04-2025
- Dividend Yield
- THFF 3.60%
- ARCT N/A
- EPS Growth
- THFF N/A
- ARCT N/A
- EPS
- THFF 4.63
- ARCT N/A
- Revenue
- THFF $215,577,000.00
- ARCT $143,680,000.00
- Revenue This Year
- THFF $29.97
- ARCT N/A
- Revenue Next Year
- THFF $2.84
- ARCT $34.79
- P/E Ratio
- THFF $12.24
- ARCT N/A
- Revenue Growth
- THFF 9.26
- ARCT 15.38
- 52 Week Low
- THFF $38.61
- ARCT $8.04
- 52 Week High
- THFF $57.43
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- THFF 63.25
- ARCT 54.34
- Support Level
- THFF $55.29
- ARCT $13.10
- Resistance Level
- THFF $57.18
- ARCT $15.20
- Average True Range (ATR)
- THFF 1.33
- ARCT 1.02
- MACD
- THFF 0.21
- ARCT 0.07
- Stochastic Oscillator
- THFF 76.19
- ARCT 55.21
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.